Return to homepagePandemic Pact

SARSCoV-2 COVID-19 Vaccine in an Enhanced Poxvirus Platform

  • Funded by North Carolina Biotechnology Center
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $20,000

  • Funder

    North Carolina Biotechnology Center

  • Principal Investigator

    Rachel Roper

  • Research Location

    United States of America

  • Lead Research Institution

    East Carolina University

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This project will produce and test several vaccines against SARS-CoV-2 virus using a patented poxvirus platform to generate enhanced immune responses and increased protection against the virus.